世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

折り畳み式IOL(眼内レンズ):医療機器パイプライン評価 2017年

Foldable IOL (Intraocular Lens) - Medical Devices Pipeline Assessment, 2017

 

出版社 出版年月電子版価格 ページ数
GlobalData
グローバルデータ
2017年9月US$4,000
シングルユーザライセンス
110

サマリー

Foldable IOL (Intraocular Lens) - Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, “Foldable IOL (Intraocular Lens) - Medical Devices Pipeline Assessment, 2017" provides an overview of Foldable IOL (Intraocular Lens) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Foldable IOL (Intraocular Lens) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Foldable IOL (Intraocular Lens) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Foldable IOL (Intraocular Lens) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Foldable IOL (Intraocular Lens) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

目次

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 7
2 Introduction 8
2.1 Foldable IOL (Intraocular Lens) Overview 8
3 Products under Development 9
3.1 Foldable IOL (Intraocular Lens) - Pipeline Products by Stage of Development 9
3.2 Foldable IOL (Intraocular Lens) - Pipeline Products by Segment 10
3.3 Foldable IOL (Intraocular Lens) - Pipeline Products by Territory 11
3.4 Foldable IOL (Intraocular Lens) - Pipeline Products by Regulatory Path 12
3.5 Foldable IOL (Intraocular Lens) - Pipeline Products by Estimated Approval Date 13
4 Foldable IOL (Intraocular Lens) - Pipeline Products under Development by Companies 14
4.1 Foldable IOL (Intraocular Lens) Companies - Pipeline Products by Stage of Development 14
4.2 Foldable IOL (Intraocular Lens) - Pipeline Products by Stage of Development 15
5 Foldable IOL Companies and Product Overview 18
5.1 Alcon Laboratories Inc Company Overview 18
5.1.1 Alcon Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Bausch & Lomb Inc Company Overview 19
5.2.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 Eye4Vision Ophthalmics International Company Overview 20
5.3.1 Eye4Vision Ophthalmics International Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 EyeKon Medical Inc Company Overview 21
5.4.1 EyeKon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Morcher Gmbh Company Overview 91
5.5.1 Morcher Gmbh Pipeline Products & Ongoing Clinical Trials Overview 91
5.6 Ocumetics Technology Corp Company Overview 92
5.6.1 Ocumetics Technology Corp Pipeline Products & Ongoing Clinical Trials Overview 92
5.7 Rayner Intraocular Lenses Ltd Company Overview 93
5.7.1 Rayner Intraocular Lenses Ltd Pipeline Products & Ongoing Clinical Trials Overview 93
5.8 STAAR Surgical Company Company Overview 94
5.8.1 STAAR Surgical Company Pipeline Products & Ongoing Clinical Trials Overview 94
5.9 University of Tampere Company Overview 95
5.9.1 University of Tampere Pipeline Products & Ongoing Clinical Trials Overview 95
6 Foldable IOL (Intraocular Lens) - Recent Developments 96
6.1 Aug 02, 2017: STAAR Surgical Reports Second Quarter 2017 Results 96
6.2 May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 97
6.3 May 03, 2017: STAAR Surgical Reports First Quarter 2017 Results 97
6.4 Apr 05, 2017: STAAR Surgical Names Deborah Andrews Interim CFO 98
6.5 Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 99
6.6 Mar 02, 2017: STAAR Surgical Reports Fourth Quarter 2016 Results 101
6.7 Feb 23, 2017: Calhoun Vision Becomes RxSight 102
6.8 Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 102
6.9 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results 103
6.10 Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 104
6.11 Oct 12, 2016: Bausch + Lomb Booth to Feature Wet Lab During the Annual Meeting of the American Academy of Ophthalmology in Chicago 104
6.12 Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 106
7 Appendix 107
7.1 Methodology 107
7.2 About GlobalData 110
7.3 Contact Us 110
7.4 Disclaimer 110

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る